Overview

A Study of S-740792 in Healthy Adult Study Participants

Status:
COMPLETED
Trial end date:
2025-09-24
Target enrollment:
Participant gender:
Summary
This is a 3-part study of S-740792 in healthy adult participants. Part 1 (single-ascending-dose and food effect) will investigate the safety, tolerability, and pharmacokinetics (PK) of S-740792. Part 2 (multiple-ascending-dose and drug-drug interaction) will investigate the safety, tolerability, and PK of S-740792, in addition, the effect of multiple doses of S-740792 on the PK of midazolam. Part 3 will investigate the relative bioavailability of S-740792 tablet compared to S-740792 suspension and the food effect on the PK of the S-740792 tablet.
Phase:
PHASE1
Details
Lead Sponsor:
Shionogi
Treatments:
Midazolam